Related Experiment Video
Updated: Mar 6, 2026

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
561
Cost and mortality impact of an algorithm-driven sepsis prediction system.
Jacob Calvert1, Jana Hoffman1, Christopher Barton2
1a Dascena Inc. , Hayward , CA , USA.
Journal of Medical Economics
|March 16, 2017
Summary
The InSight biomarker tool forecasts sepsis earlier than other methods, saving lives and reducing healthcare costs. This algorithm-driven approach identifies more true sepsis cases with fewer false alarms.
Area of Science:
- Biomedical informatics
- Critical care medicine
- Health economics
Background:
- Sepsis remains a leading cause of mortality and increased healthcare costs.
- Early detection of sepsis is crucial for improving patient outcomes and reducing financial burden.
- Existing sepsis screening tools have limitations in accuracy and efficiency.
Purpose of the Study:
- To evaluate the financial and mortality impact of InSight, an algorithm-driven biomarker for sepsis onset prediction.
- To compare the performance of InSight against current sepsis screening methods.
- To quantify the potential life and cost savings associated with InSight implementation.
Main Methods:
- Comparative analysis of InSight against existing sepsis screening tools.
- Calculation of mortality reduction based on increased true positive sepsis identification.
- Computation of cost savings derived from reduced length-of-stay due to early detection.
Main Results:
- InSight demonstrates superior performance in identifying severe sepsis cases with fewer false alarms compared to existing methods.
- In a 50-bed ICU, InSight is projected to save 75 additional lives annually.
- InSight is estimated to reduce sepsis-related costs by $560,000 per year for a 50-bed ICU.
Conclusions:
- InSight shows significant potential for reducing sepsis-related mortality.
- The implementation of InSight can lead to substantial cost savings for healthcare facilities.
- Further research may refine estimates by considering varied prediction times and diverse patient cohorts.